Valeant to Participate at the Deutsche Bank 25th Annual Leveraged Finance Conference

This post was originally published on this site

LAVAL, Quebec, Sept. 27, 2017 () — Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) (“Valeant”) today announced that Paul S. Herendeen, executive vice president, Finance, and chief financial officer; Linda LaGorga, senior vice president, Finance, and treasurer; and Arthur J. Shannon, senior vice president and head of Investor Relations and Communications; are scheduled to participate at the Deutsche Bank 25th Annual Leveraged Finance Conference in Scottsdale, Ariz. on Oct. 4, 2017 at 8:00 a.m. MST (11:00 a.m. EDT).


Recommended For You

mm

About the Author: Sidney Martin

Sidney Marin Is a researcher and law student at York University (TORONTO). He has worked as the Director of the Graduate Lawyering Program. He worked for American law firms in Moscow, Russia for three years. Hegraduated from Columbia Law School, Columbia School of International and Public Affairs and Harvard College. He research interest is in human rights and health law, with a particular focus on the law and policy of vaccination.